NewAmsterdam Pharma (NAMSW) Institutional Ownership → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free NAMSW Stock Alerts $9.30 -0.09 (-0.96%) (As of 11:10 AM ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for NewAmsterdam Pharma (NASDAQ:NAMSW)Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$1.20MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$13.99K Get NAMSW Insider Trade Alerts Want to know when executives and insiders are buying or selling NewAmsterdam Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NAMSW Institutional Buying and Selling by Quarter Ad Stansberry ResearchA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more potential than the AI stocks most investors are focused on in the days ahead.To get its name and ticker symbol for free - just click here. NewAmsterdam Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2024 Affinity Asset Advisors LLC202,599$2.24M0.3%+47.9%0.000% 2/15/2024 Clear Street LLC8,993$28K0.0%-33.2%0.000% 2/14/2024 ADAR1 Capital Management LLC82,857$259K0.1%N/A0.000% 11/15/2023 Affinity Asset Advisors LLC137,000$260K0.1%+270.3%0.000% 8/7/2023 Wolverine Asset Management LLC12,448$26K0.0%N/A0.000% 5/15/2023 Affinity Asset Advisors LLC37,000$68K0.0%N/A0.000% 5/12/2023 Clear Street LLC17,619$32K0.0%N/A0.000% 5/11/2023 Highbridge Capital Management LLC733,327$1.36M0.0%+4.0%0.000% 5/10/2023Exos TFP Holdings LLC93,932$173K0.0%-31.6%0.000% 2/14/2023 RA Capital Management L.P.333,333$289K0.0%N/A0.000% 2/14/2023 EcoR1 Capital LLC66,665$727K0.0%N/A0.000% 2/10/2023Exos TFP Holdings LLC137,317$119K0.0%N/A0.000% 2/3/2023 Frazier Life Sciences Management L.P.500,333$434K0.0%N/A0.000% (Data available from 1/1/2016 forward) NAMSW Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NAMSW shares? During the previous two years, 9 institutional investors and hedge funds held shares of NewAmsterdam Pharma. The most heavily invested institutionals were Affinity Asset Advisors LLC ($2.24M), Highbridge Capital Management LLC ($1.36M), EcoR1 Capital LLC ($727K), Frazier Life Sciences Management L.P. ($434K), RA Capital Management L.P. ($289K), ADAR1 Capital Management LLC ($259K), and Exos TFP Holdings LLC ($173K).Learn more on NAMSW's institutional investors. Which institutional investors have been buying NewAmsterdam Pharma stock? Of the 9 institutional investors that purchased NewAmsterdam Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Frazier Life Sciences Management L.P. ($500.33K), RA Capital Management L.P. ($333.33K), Affinity Asset Advisors LLC ($202.60K), Exos TFP Holdings LLC ($137.32K), ADAR1 Capital Management LLC ($82.86K), EcoR1 Capital LLC ($66.67K), and Highbridge Capital Management LLC ($27.98K). How much institutional buying is happening at NewAmsterdam Pharma? Institutional investors have bought a total of 1,381,146 shares in the last 24 months. This purchase volume represents approximately $2.25M in transactions. Which NewAmsterdam Pharma major shareholders have been selling company stock? The following institutional investors have sold NewAmsterdam Pharma stock in the last 24 months: Exos TFP Holdings LLC ($43.39K), and Clear Street LLC ($4.47K). How much institutional selling is happening at NewAmsterdam Pharma? Institutional investors have sold a total of 47,855 shares in the last 24 months. This volume of shares sold represents approximately $93.82K in transactions. Related Companies: Alpha Tau Medical Major Shareholders Apollomics Major Shareholders BriaCell Therapeutics Major Shareholders Celularity Major Shareholders Fortress Biotech Major Shareholders Humacyte Major Shareholders Immatics Major Shareholders Jasper Therapeutics Major Shareholders OmniAb Major Shareholders This page (NASDAQ:NAMSW) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldUrgent Nvidia WarningAltimetryThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewAmsterdam Pharma Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
